-
1 Comment
Guangxi Liuzhou Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 9.0% below its 200 day moving average.
From a valuation standpoint, the stock is 94.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
Guangxi Liuzhou Pharmaceutical Co., Ltd's total revenue rose by 4.4% to $4B since the same quarter in the previous year.
Its net income has dropped by 25.1% to $103M since the same quarter in the previous year.
Finally, its free cash flow grew by 20.9% to $1B since the same quarter in the previous year.
Based on the above factors, Guangxi Liuzhou Pharmaceutical Co., Ltd gets an overall score of 3/5.
| CurrencyCode | CNY |
|---|---|
| Sector | Healthcare |
| Industry | Medical Distribution |
| ISIN | CNE100001VR3 |
| Exchange | SHG |
| Target Price | 24.16 |
|---|---|
| Market Cap | 7B |
| PE Ratio | 7.68 |
| Beta | 0.43 |
| Dividend Yield | None |
Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It also offers smart medicine value-added services. The company was founded in 1981 and is based in Liuzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603368.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
